Back to something else, again, ....
vamorolone got (will get) $75m upfront for nth america deal (milestones, % sales etc etc as well) . Vamorolone could replace steroids having very similar efficacy to steroids, (but remember our drug works on top of steroids, so vamorolone could be the base, plus ATL1102 on top to get best outcomes).
$75m usd closer to the mark for our discussion points, or a lot higher than CAPs 30m.
anp chart, page-912
-
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
